Skip to content
☰ Menu
Preprint · CC-BY via OpenAlex

Design, synthesis of urolithin A, the metabolite of ellagitannins, and its biological activity of phosphodiesterase II (PDE2) inhibitors

Huanzhou Li, Feng Zhou, Qin Hu, Long Tang, Aibin Zheng

Research Square · 2025

Deregulated nutrient-sensing
＋ Sign in to save

Abstract

This Research Square 2025 study details the design and synthesis of urolithin A and evaluates its potential as a phosphodiesterase II inhibitor.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.21203/rs.3.rs-7383061/v1
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
Li, H., Zhou, F., Hu, Q., Tang, L., &amp; Zheng, A. (2025). Design, synthesis of urolithin A, the metabolite of ellagitannins, and its biological activity of phosphodiesterase II (PDE2) inhibitors. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-7383061/v1
Vancouver
Li H, Zhou F, Hu Q, Tang L, Zheng A. Design, synthesis of urolithin A, the metabolite of ellagitannins, and its biological activity of phosphodiesterase II (PDE2) inhibitors. Research Square. 2025. doi:10.21203/rs.3.rs-7383061/v1.
BibTeX
@unpublished{huanzhou2025Design, title = {Design, synthesis of urolithin A, the metabolite of ellagitannins, and its biological activity of phosphodiesterase II (PDE2) inhibitors}, author = {Huanzhou Li and Feng Zhou and Qin Hu and Long Tang and Aibin Zheng}, journal = {Research Square}, year = {2025}, doi = {10.21203/rs.3.rs-7383061/v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings